Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
RNST
|
Ted E Parker
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 4,455 Added 0.0% |
-
|
Apr 01
2025 |
|
RNST
|
Ted E Parker
Director |
BUY
Grant, award, or other acquisition
|
Direct | 87,921 Added 50.0% |
-
|
Apr 01
2025 |
|
RNST
|
Diana Renee Moore
Director |
BUY
Grant, award, or other acquisition
|
Direct | 7,264 Added 50.0% |
-
|
Apr 01
2025 |
|
RNST
|
M Ray Cole Jr
SEVP and Executive Advisor |
BUY
Grant, award, or other acquisition
|
Indirect | 7,488 Added 0.0% |
-
|
Apr 01
2025 |
|
RNST
|
M Ray Cole Jr
SEVP and Executive Advisor |
BUY
Grant, award, or other acquisition
|
Direct | 121,986 Added 50.0% |
-
|
Apr 01
2025 |
|
LEA
|
Kathleen Ligocki |
BUY
Exercise of conversion of derivative security
|
Direct | 53 Added 1.42% |
-
|
Apr 01
2025 |
|
ALV
|
Fabien Dumont
EVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 975 Reduced 23.72% |
$86,238
$88.45 p/Share
|
Mar 31
2025 |
|
ALV
|
Fabien Dumont
EVP & Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 2,471 Added 37.55% |
-
|
Mar 31
2025 |
|
HCSG
|
Kurt Simmons Jr
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,489 Added 6.37% |
$15,009
$10.08 p/Share
|
Mar 31
2025 |
|
HCSG
|
Robert L Frome
Director |
BUY
Grant, award, or other acquisition
|
Direct | 249 Added 0.91% |
$2,509
$10.08 p/Share
|
Mar 31
2025 |
|
NTRA
|
Steven Leonard Chapman
CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct | 9,563 Reduced 4.31% |
$1,323,710
$138.42 p/Share
|
Mar 31
2025 |
|
NTRA
|
Michael Burkes Brophy
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 2,562 Reduced 3.28% |
$354,555
$138.39 p/Share
|
Mar 31
2025 |
|
VRA
|
Mark C Dely
CHIEF ADMINISTRATIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 3,233 Reduced 1.93% |
$7,468
$2.31 p/Share
|
Mar 31
2025 |
|
VRA
|
Alison Hiatt
CHIEF MARKETING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 2,660 Reduced 5.48% |
$6,144
$2.31 p/Share
|
Mar 31
2025 |
|
MDV
|
Thomas H Nolan Jr
Director |
BUY
Grant, award, or other acquisition
|
Direct | 934 Added 3.48% |
$14,990
$16.05 p/Share
|
Mar 31
2025 |
|
MDV
|
Connie Tirondola
Director |
BUY
Grant, award, or other acquisition
|
Direct | 934 Added 7.83% |
$14,990
$16.05 p/Share
|
Mar 31
2025 |
|
MDV
|
Christopher Raymond Gingras
Director |
BUY
Grant, award, or other acquisition
|
Direct | 934 Added 12.58% |
$14,990
$16.05 p/Share
|
Mar 31
2025 |
|
MDV
|
Kimberly J Smith
Director |
BUY
Grant, award, or other acquisition
|
Direct | 934 Added 6.68% |
$14,990
$16.05 p/Share
|
Mar 31
2025 |
|
NTRA
|
Daniel Rabinowitz
SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct | 1,404 Reduced 0.62% |
$194,313
$138.4 p/Share
|
Mar 31
2025 |
|
REAL
|
Karen Katz
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,014 Added 1.45% |
-
|
Mar 31
2025 |
|
REAL
|
Niki Leondakis
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,623 Added 0.9% |
-
|
Mar 31
2025 |
|
FSLR
|
Venkata S M Renduchintala
Director |
BUY
Grant, award, or other acquisition
|
Direct | 356 Added 26.39% |
-
|
Mar 31
2025 |
|
FSLR
|
Norman L. Wright
Director |
BUY
Grant, award, or other acquisition
|
Direct | 356 Added 8.43% |
-
|
Mar 31
2025 |
|
FSLR
|
Paul H Stebbins
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 356 Added 0.0% |
-
|
Mar 31
2025 |
|
FSLR
|
Michael T Sweeney
Director |
BUY
Grant, award, or other acquisition
|
Direct | 356 Added 1.97% |
-
|
Mar 31
2025 |
|
FSLR
|
Molly Joseph
Director |
BUY
Grant, award, or other acquisition
|
Direct | 356 Added 2.19% |
-
|
Mar 31
2025 |
|
FSLR
|
Lisa A Kro
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 356 Added 0.0% |
-
|
Mar 31
2025 |
|
FSLR
|
William J Post
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 356 Added 0.0% |
-
|
Mar 31
2025 |
|
ENOV
|
Angela S Lalor |
BUY
Grant, award, or other acquisition
|
Direct | 589 Added 4.26% |
-
|
Mar 31
2025 |
|
AWH
|
Winfred Parnell
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 5,156 Added 7.24% |
-
|
Mar 31
2025 |
|
FSLR
|
Anita M. George
Director |
BUY
Grant, award, or other acquisition
|
Direct | 356 Added 7.76% |
-
|
Mar 31
2025 |
|
CRWV
|
Cw Opportunity LLC
> 10% Shareholder |
BUY
Conversion of derivative security
|
Direct | 29,545,300 Added 50.0% |
-
|
Mar 31
2025 |
|
CRWV
|
Magnetar Financial LLC
> 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect | 69,339,288 Added 0.0% |
-
|
Mar 31
2025 |
|
AWH
|
Ellen Beausang
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,615 Added 50.0% |
-
|
Mar 31
2025 |
|
FSLR
|
Michael J Ahearn
Director |
BUY
Grant, award, or other acquisition
|
Direct | 505 Added 0.78% |
-
|
Mar 31
2025 |
|
CURV
|
Chinwe Abaelu
Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,477 Reduced 1.05% |
$8,093
$5.48 p/Share
|
Mar 31
2025 |
|
GLDD
|
Earl L Shipp |
BUY
Grant, award, or other acquisition
|
Direct | 5,057 Added 11.45% |
-
|
Mar 31
2025 |
|
GTE
|
Ronald Royal
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 4,798 Reduced 100.0% |
$23,606
$4.92 p/Share
|
Mar 31
2025 |
|
GTE
|
Ronald Royal
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 4,798 Added 50.0% |
$23,606
$4.92 p/Share
|
Mar 31
2025 |
|
GLDD
|
Dana A Armstrong |
BUY
Grant, award, or other acquisition
|
Direct | 4,833 Added 50.0% |
-
|
Mar 31
2025 |
|
GLDD
|
D Michael Steuert |
BUY
Grant, award, or other acquisition
|
Direct | 5,057 Added 5.24% |
-
|
Mar 31
2025 |
|
GDNSF
|
Chicago Atlantic Credit Opportunities, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 71,600 Added 12.82% |
$30,788
$0.43 p/Share
|
Mar 31
2025 |
|
STKS
|
Susan Lintonsmith |
BUY
Grant, award, or other acquisition
|
Direct | 8,779 Added 11.73% |
-
|
Mar 31
2025 |
|
STKS
|
Haydee Olinger |
BUY
Grant, award, or other acquisition
|
Direct | 8,779 Added 10.38% |
-
|
Mar 31
2025 |
|
STKS
|
Dimitrios Angelis |
BUY
Grant, award, or other acquisition
|
Direct | 8,779 Added 5.94% |
-
|
Mar 31
2025 |
|
STKS
|
Michael Serruya |
BUY
Grant, award, or other acquisition
|
Direct | 8,779 Added 3.15% |
-
|
Mar 31
2025 |
|
ACHR
|
Thomas Paul Muniz
CHIEF TECHNOLOGY OFFICER |
SELL
Open market or private sale
|
Direct | 52,958 Reduced 4.32% |
$372,824
$7.04 p/Share
|
Mar 31
2025 |
|
ACHR
|
Mark Mesler
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 34,498 Reduced 4.97% |
$242,865
$7.04 p/Share
|
Mar 31
2025 |
|
ACHR
|
Tosha Perkins
CHIEF PEOPLE PARTNERSHIPS OFF. |
SELL
Open market or private sale
|
Direct | 33,335 Reduced 11.26% |
$234,678
$7.04 p/Share
|
Mar 31
2025 |
|
STKS
|
Eugene M Bullis |
BUY
Grant, award, or other acquisition
|
Direct | 8,779 Added 4.06% |
-
|
Mar 31
2025 |